DAILIES™ AquaComfort™

  1. Wolffsohn, J, Hunt, O, Chowdhury, A. Objective clinical performance of ‘comfort enhanced’ daily disposable soft contact lenses. Contact Lens & Anterior Eye. 2010;33:88-92.
  2. Pruitt, J, Winterton, L. Triple-action moisturisers for increased comfort in daily disposable lenses, Optician 2007; 16.11: 27-28.
  3. Nichols JJ, Willcox MDP, Bron AJ, et al. The TFOS International Workshop on Contact Lens Discomfort: Executive Summary. Invest Ophthalmol Vis Sci. 2013;54:TFOS7–TFOS13. DOI:10.1167/iovs.13-13212
  4. White CJ, Thomas CR, Byrne ME. Bringing comfort to the masses: a novel evaluation of comfort agent solution properties. Cont Lens Anterior Eye. 2014 Apr;37(2):81-91.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-DAP-2400005

DAILIES™ AquaComfort™ PLUS Toric

* Based on Focus™ DAILIES™ Toric contact lenses.

^ Based on DAILIES™ AquaComfort™ PLUS sphere contact lenses.

† Based on investigator assessment of lens rotation, at one week; using investigational lenses with -.75, -1.5 cylinder powers (D).

  1. PRECISION CURVE: Outstanding stability and clear vision. CLM-DAT-GLB-0003. Alcon data on file, 2019.
  2. Wolffsohn, J, Hunt, O, Chowdhury, A. Objective clinical performance of ‘comfort enhanced’ daily disposable soft contact lenses. Contact Lens & Anterior Eye. 2010;33:88-92.
  3. Pruitt, J, Winterton, L. Triple-action moisturisers for increased comfort in daily disposable lenses, Optician 2007; 16.11: 27-28.
  4. Nichols JJ, Willcox MDP, Bron AJ, et al. The TFOS International Workshop on Contact Lens Discomfort: Executive Summary. Invest Ophthalmol Vis Sci. 2013;54:TFOS7–TFOS13. DOI:10.1167/iovs.13-13212
  5. White CJ, Thomas CR, Byrne ME. Bringing comfort to the masses: a novel evaluation of comfort agent solution properties. Cont Lens Anterior Eye. 2014 Apr;37(2):81-91.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-DAT-2400001

DAILIES™ AquaComfort™ PLUS Multifocal

^ Based on DAILIES™ AquaComfort™ PLUS sphere contact lenses.

  1. Alcon's PPD Design smooth progression of powers (v0.1). CLM-DTM-GLB-0016. Alcon data on file, 2013.
  2. Wolffsohn, J, Hunt, O, Chowdhury, A. Objective clinical performance of ‘comfort enhanced’ daily disposable soft contact lenses. Contact Lens & Anterior Eye. 2010;33:88-92.
  3. Pruitt, J, Winterton, L. Triple-action moisturisers for increased comfort in daily disposable lenses, Optician 2007; 16.11: 27-28.
  4. Nichols JJ, Willcox MDP, Bron AJ, et al. The TFOS International Workshop on Contact Lens Discomfort: Executive Summary. Invest Ophthalmol Vis Sci. 2013;54:TFOS7–TFOS13. DOI:10.1167/iovs.13-13212
  5. White CJ, Thomas CR, Byrne ME. Bringing comfort to the masses: a novel evaluation of comfort agent solution properties. Cont Lens Anterior Eye. 2014 Apr;37(2):81-91.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-DAM-2400001

PRECISION1™

*Based on in vitro measurements of unworn lenses.

‡WARNING: UV Absorbing contact lenses are not substitutes for protective UV absorbing eye wear such as UV absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. The patient should continue to use UV absorbing eyewear as directed.

  1. A01660-REP-044605 v2 Precision1 Lens with Smart Surface. Alcon data on file, 2019.
  2. Cummings S, Giedd B, Pearson C. Clinical Performance of a Novel Daily Disposable Soft Contact Lens. JCLRS [Internet]. 2020Dec.11;4(1):e23-e30.
  3. ANSI Z80.20-2016 Ophthalmic contact lens UV transmittance
  4. ISO 18369-2:2017 Ophthalmic optics — Contact lenses — Part 2: Tolerances / Table 4 Tolerance Limits

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-PR1-2400024

DAILIES TOTAL1™

*Based on 9/10 wearers agreeing with the statement 'while wearing my lenses, I sometimes forget I have them on'

**High oxygen transmissible lenses, DK/T=156 @ -3.00. Based on published manufacturer- provided Dk and thickness values in: Tyler's Quarterly Soft Contact Lens Parameter Guide. Dec 2020.

†Compared to 1-DAY ACUVUE TruEye and clariti 1-day.

#Based on in vitro measurements of unworn lenses.

  1. Perez-Gomez I, Giles T. European survey of contact lens wearers and eye care professionals on satisfaction with a new water gradient disposable contact lens. Clin Optom. 2014;6:17-23.
  2. Belda-Salmerón L, Ferrer-Blasco T, Albarrán-Diego C, Madrid-Costa D, Montés-Micó R. Diurnal variations in visual performance for disposable contact lenses. Optom Vis Sci. 2013;90(7):682-690.
  3. Angelini TE, Nixon RM, Dunn AC, et al. Viscoelasticity and mesh-size at the surface of hydrogels characterized with microrheology. Invest Ophthalmol Vis Sci. 2013;54:E-abstract 500.
  4. Thekveli S, Qui Y, Kapoor Y, et al. Structure-property relationship of delefilcon A lenses. Cont Lens Anterior Eye. 2012;35(suppl 1):e14.
  5. Pitt WG, Jack DR, Zhao Y, Nelson JL, Pruitt JD. Loading and release of a phospholipid from contact lenses. Optom Vis Sci. 2011;88(4):502-506.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-DT1-2400023

DAILIES TOTAL1™ for Astigmatism

*Based on in vitro measurements of unworn lenses.

**Based on lens movement, centration, and rotation at initial fitting.

†UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. The patient should continue to use UV-absorbing eyewear as directed.

  1. In a clinical trial to assess overall performance of DAILIES TOTAL1® for Astigmatism lenses where n=134 patients. Alcon data on file, 2021.
  2. In a clinical trial to evaluate stability of axis orientation of DAILIES TOTAL1® for Astigmatism lenses where n=47. Alcon data on file, 2020.
  3. Young G, Sulley A, Hunt C. Prevalence of astigmatism in relation to soft contact lens fitting. Eye Contact Lens. 2011;37:20-25.
  4. Thekveli S, Qui Y, Kapoor Y, et al. Structure-property relationship of delefilcon A lenses. Cont Lens Anterior Eye. 2012;35(Supp 1):e14.
  5. Angelini TE, Nixon RM, Dunn AC, et al. Viscoelasticity and mesh-size at the surface of hydrogels characterized with microrheology. Invest Ophthalmol Vis Sci. 2013;54:E-abstract 500.
  6. Pitt W, Jack D, Zhao Y, Nelson J, Pruitt J. Loading and release of a phospholipid from contact lenses. Optom Vis Sci. 2011; 88(4):502-506.
  7. Laboratory assessment of ultraviolet and visible light transmission properties of lehfilcon A contact lenses using spectrophotometer. Alcon data on file, 2020.

See product instructions for complete wear, care and safety information.© 2024 Alcon Inc. CA-DTA-2400012

DAILIES TOTAL1™ Multifocal

*Based on in vitro measurements of unworn lenses.

  1. Alcon data on file, 2017.
  2. Perez-Gomez I, Giles T. European survey of contact lens wearers and eye care professionals on satisfaction with a new water gradient daily disposable contact lens. Clin Optom. 2014;6:17-23.
  3. Alcon data on file, 2016.
  4. Lemp J, Kern J. Alcon multifocal contact lenses for presbyopia correction. Paper presented at the Canadian Association of Optometrists Congress; June 28-30, 2017; Ottawa, ON
  5. Merchea M, Evans D, Kannarr S, et al. Patient and ECP Satisfaction in the United States with a Novel Water Gradient Daily Disposable Multifocal Contact Lens. Presented at the American Optometric Association Annual Meeting, June 20-24, 2018. Denver, CO.
  6. Thekveli S, Qui Y, Kapoor Y, et al. Structure-property relationship of delefilcon A lenses. Cont Lens Anterior Eye. 2012;35(Supp 1):e14.
  7. Angelini TE, Nixon RM, Dunn AC, et al. Viscoelasticity and mesh-size at the surface of hydrogels characterized with microrheology. Invest Ophthalmol Vis Sci. 2013;54:E-abstract 500.
  8. Pitt W, Jack D, Zhao Y, Nelson J, Pruitt J. Loading and release of a phospholipid from contact lenses. Optom Vis Sci. 2011; 88(4):502-506.
  9. Baker K, Merchea M. Impact of pupil diameter on multifocal contact lens vision. Poster presented at American Academy of Optometry Annual Conference, November 9, 2018. San Antonio, Texas.
  10. Bauman E, Lemp J, Kern J. Material effect on multifocal contact lens fitting of lenses of the same optical design with the same fitting guide. Poster presented at the British Contact Lens Association (BCLA) Clinical Conference and Exhibition, June 9-11, 2017. Liverpool, UK.
  11. Merchea M, Evans D, Kannarr S, et al. Assessing a modified fitting approach for improved multifocal contact lens fitting success. Presented at the American Optometric Association Annual Meeting, June 21-25, 2018. Denver, CO.

See product instructions for complete wear, care and safety information.© 2024 Alcon Inc. © 2024 Alcon Inc. CA-DTM-2400009

AIR OPTIX™ plus HydraGlyde™

*Based on studies with AIR OPTIX® AQUA contact lenses.

  1. Eiden SB, Davis RL, Bergenske PD. Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective and subjective measures of health, comfort, and vision. Eye & Contact Lens. 2013;39(4):290-294.
  2. Based on a 30-day clinical study of 75 habitual lotrafilcon B lens wearers. Alcon data on file, 2017.
  3. Lemp J, Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93:Eabstract 165256.
  4. In vitro study over 16 hours to measure wetting substantivity. Alcon data on file, 2015.
  5. Muya L, Lemp J, Kern JR, Sentell KB, Lane J, Perry SS. Impact of packaging saline wetting agents on wetting substantivity and lubricity. Invest Opthalmol Vis Sci. 2016;57:E- abstract 1463.
  6. Lemp J, Kern J. On-eye performance of lotrafilcon B lenses packaged with a substantive wetting agent. Poster presented at Optometry’s Meeting, the Annual Meeting of the American Optometric Association; June 21-25, 2017; Washington, D.C.
  7. Nash W, Gabriel M, Movrewy Mckee M. A comparison of various silicone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci. 2010;87: E-abstract 105110.
  8. Nash W. Gabriel M. Ex vivo analysis of cholesterol deposition for commercially available silicone hydrogel contact lenses using a fluorometric enzymatic assay. Eye Contact Lens. 2014;40(5):277-282.
  9. CLA560-P001 TDOC-0051304 One month clinical comparison of lotrafilcon B and samfilcon A. Alcon data on file, 2016.
  10. MEMO - Pruitt - 17-Dec-2013 Surface mobility of silicone in Air Optix lenses. Alcon data on file, 2013.
  11. Rex J, Perry S, Lemp J. Concentrations of Silicon at Silicone Hydrogel Contact Lens Surfaces. Poster presented at BCLA Clinical Conference; May 29-31, 2015; Liverpool, England.
  12. Guillon M, Maissa C, Wong S, Patel K, Lemp J. Tear film dynamics over silicone hydrogel contact lenses with different lipid deposition profiles. Optom Vis Sci. 2014;91:E-abstract 145196.
  13. In vitro study over 16 hours, to measure wetting substantivity. Alcon data on file, 2015.
  14. Muya L, Lemp J, Kern JR, Sentell KB, Lane J, Perry SS. Impact of packaging saline wetting agents on wetting substantivity and lubricity. Invest Opthalmol Vis Sci. 2016;57:E-abstract 1463.

Important information for AIR OPTIX® plus HydraGlyde® (lotrafilcon B) contact lenses: For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-AHG-2400001

AIR OPTIX™ plus HydraGlyde™ for Astigmatism

*Based on studies with AIR OPTIX® AQUA contact lenses.

**Based on clinical studies with AIR OPTIX™ for Astigmatism contact lenses.

  1. Eiden SB, Davis RL, Bergenske PD. Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective and subjective measures of health, comfort, and vision. Eye & Contact Lens. 2013;39(4):290-294.
  2. Based on a 30-day clinical study of 75 habitual lotrafilcon B lens wearers. Alcon data on file, 2017.
  3. Lemp J, Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93:Eabstract 165256.
  4. In vitro study over 16 hours to measure wetting substantivity. Alcon data on file, 2015.
  5. Muya L, Lemp J, Kern JR, Sentell KB, Lane J, Perry SS. Impact of packaging saline wetting agents on wetting substantivity and lubricity. Invest Opthalmol Vis Sci. 2016;57:E- abstract 1463.
  6. Lemp J, Kern J. On-eye performance of lotrafilcon B lenses packaged with a substantive wetting agent. Poster presented at Optometry’s Meeting, the Annual Meeting of the American Optometric Association; June 21-25, 2017; Washington, D.C.
  7. Nash W, Gabriel M, Movrewy Mckee M. A comparison of various silicone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci. 2010;87: E-abstract 105110.
  8. Nash W. Gabriel M. Ex vivo analysis of cholesterol deposition for commercially available silicone hydrogel contact lenses using a fluorometric enzymatic assay. Eye Contact Lens. 2014;40(5):277-282.
  9. CLA560-P001 TDOC-0051304 One month clinical comparison of lotrafilcon B and samfilcon A. Alcon data on file, 2016.
  10. MEMO - Pruitt - 17-Dec-2013 Surface mobility of silicone in Air Optix lenses. Alcon data on file, 2013.
  11. Rex J, Perry S, Lemp J. Concentrations of Silicon at Silicone Hydrogel Contact Lens Surfaces. Poster presented at BCLA Clinical Conference; May 29-31, 2015; Liverpool, England.
  12. Guillon M, Maissa C, Wong S, Patel K, Lemp J. Tear film dynamics over silicone hydrogel contact lenses with different lipid deposition profiles. Optom Vis Sci. 2014;91:E-abstract 145196.
  13. In vitro study over 16 hours, to measure wetting substantivity. Alcon data on file, 2015.
  14. Muya L, Lemp J, Kern JR, Sentell KB, Lane J, Perry SS. Impact of packaging saline wetting agents on wetting substantivity and lubricity. Invest Opthalmol Vis Sci. 2016;57:E-abstract 1463.
  15. In a randomized, subject-masked, multi-site clinical study with over 150 patients; significance demonstrated at the 0.05 level. Alcon data on file, 2005.
  16. R-242-C-007- Sub 1, 2, 3 O2 Optix-Biomedics, Soflens 66, Frequency 55 Toric Daily Wear US Trials. Alcon data on file, 2005.

Important information for AIR OPTIX® plus HydraGlyde® (lotrafilcon B) contact lenses: For daily wear or extended wear up to 6 nights for near/far-sightedness. Risk of serious eye problems (i.e., corneal ulcer) is greater for extended wear. In rare cases, loss of vision may result. Side effects like discomfort, mild burning or stinging may occur.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-AHA-2400001

AIR OPTIX™ NIGHT&DAY™ AQUA

†Extended wear for up to 30 continuous nights, as prescribed by an eye care professional.

*Dk/t = 175 @ -3.00D. Other factors may impact eye health.

  1. AIR OPTIX™ NIGHT & DAY™ AQUA package insert.
  2. Based on the ratio of lens oxygen transmissibilities. Alcon data on file, 2009, 2010.
  3. Lemp J, Kern J. On-eye performance of lotrafilcon B lenses packaged with a substantive wetting agent. Poster presented at Optometry's Meeting, the Annual Meeting of the American Optometric Association; June 21-25, 2017; Washington, D.C.
  4. Nash W, Gabriel M, Mowrey-McKee M. A comparison of various silicone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci. 2010;87: E-abstract 105110.
  5. Nash WL, Gabriel MM. Ex vivo analysis of cholesterol deposition for commercially available silicone hydrogel contact lenses using a fluorometric enzymatic assay. Eye Contact Lens. 2014;40(5):277-282.

Important information for AIR OPTIX® NIGHT & DAY® AQUA (lotrafilcon A) contact lenses: Indicated for vision correction for daily wear (worn only while awake) or extended wear (worn while awake and asleep) for up to 30 nights. Relevant Warnings: A corneal ulcer may develop rapidly and cause eye pain, redness or blurry vision as it progresses. If left untreated, a scar, and in rare cases loss of vision, may result. The risk of serious problems is greater for extended wear vs. daily wear and smoking increases this risk. A one-year post-market study found 0.18% (18 out of 10,000) of wearers developed a severe corneal infection, with 0.04% (4 out of 10,000) of wearers experiencing a permanent reduction in vision by two or more rows of letters on an eye chart. Relevant Precautions: Not everyone can wear for 30 nights. Approximately 80% of wearers can wear the lenses for extended wear. About two-thirds of wearers achieve the full 30 nights continuous wear. Side Effects: In clinical trials, approximately 3-5% of wearers experience at least one episode of infiltrative keratitis, a localized inflammation of the cornea which may be accompanied by mild to severe pain and may require the use of antibiotic eye drops for up to one week. Other less serious side effects were conjunctivitis, lid irritation or lens discomfort including dryness, mild burning or stinging. Contraindications: Contact lenses should not be worn if you have: eye infection or inflammation (redness and/or swelling); eye disease, injury or dryness that interferes with contact lens wear; systemic disease that may be affected by or impact lens wear; certain allergic conditions or using certain medications (ex. some eye medications). Additional Information: Lenses should be replaced every month. If removed before then, lenses should be cleaned and disinfected before wearing again. Always follow the eye care professional’s recommended lens wear, care and replacement schedule. Consult package insert for complete information, available without charge by calling (800) 241-5999 or go to myalcon.com.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-AON-2400001

AIR OPTIX™ COLORS

*Dk/t = 138 @ -3.00D. Other factors may impact eye health

  1. AIR OPTIX COLORS contact lenses: Comfort and breathability. CLM-AOC-US-0001. Alcon data on file, 2013.
  2. In vitro study over 16 hours to measure wetting substantivity. Alcon data on file, 2015.
  3. Eiden SB, Davis, R, Bergenske P. Prospective study of lotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective and subjective measures of health, comfort and vision. Eye Contact Lens. 2013;39(4):290-294.
  4. Lemp J. Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93E-abstract 165256.
  5. Smartshield Technology shields from irritating deposits for consistent comfort all month long. CLM-AOA-GLB-0009. Alcon data on file, 2014.

Important information for AIR OPTIX® COLORS (lotrafilcon B) contact lenses: For daily wear only for near/far-sightedness. Contact lenses, even if worn for cosmetic reasons, are prescription medical devices that must only be worn under the prescription, direction and supervision of an eye care professional. Serious eye health problems may occur as a result of sharing contact lenses. Although rare, serious eye problems can develop while wearing contact lenses. Side effects like discomfort, mild burning or stinging may occur. To help avoid these problems, patients must follow the wear and replacement schedule and the lens care instructions provided by their eye doctor.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-AOC-2400001

TOTAL30™

*Based on in vitro measurements of unworn lenses.

**There is no demonstrated clinical benefit to a 34% reduction in visible light at wavelengths below 450 nm.

‡UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. The patient should continue to use UV-absorbing eyewear as directed.

  1. In a clinical study wherein patients (n=66) used AOSEPT® solution for nightly cleaning, disinfecting, and storing. Alcon data on file, 2021.
  2. Surface observations of lehfilcon A contact lens and human cornea using scanning transmissions electron microscopy. Alcon data on file, 2020.
  3. Shi X, Cantu-Crouch D, Sharma V, et al. Surface characterization of a silicone hydrogel contact lens having bioinspired 2-methacryloyloxyethyl phosphorylcholine polymer layer in hydrated state. Colloids Surf B: Biointerfaces. March 2021;199:111539.
  4. In vitro evaluation of bacterial adherence in commercial lenses. Alcon data on file, 2020.
  5. In vitro evaluation of bacterial biofilm in commercial lenses. Alcon data on file, 2020.
  6. Ishihara K, Fukazawa K, Sharma V, Liang S, et al. Antifouling silicone hydrogel contact lenses with a bioinspired 2 methacryloyloxyethyl phosphorylcholine polymer surface. ACS Omega. 2021;6:7058-7067.
  7. In vitro evaluation of lipid deposition for lehfilcon A and commercial lenses using 3D confocal imaging. Alcon data on file, 2021.
  8. In vitro analysis of lens oxygen permeability, water content, and surface imaging. Alcon data on file, 2021.
  9. In vitro analysis of lehfilcon A contact lenses outermost surface softness and correlation with water content. Alcon data on file, 2021.
  10. Laboratory measurement of oxygen permeability by polarographic method. Alcon data on file, 2019.
  11. Laboratory assessment of ultraviolet and visible light transmission properties of lehfilcon A contact lenses using spectrophotometer. Alcon data on file, 2020.

See product instructionsl for complete wear, care and safety information. © 2024 Alcon Inc. CA-T30-2400035

TOTAL30™ for Astigmatism

*Based on in vitro measurements of unworn lenses.

**Based on lens movement, centration, and rotation at initial fitting.

***There is no demonstrated clinical benefit to a 34% reduction in visible light at wavelengths below 450 nm.

†UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. The patient should continue to use UV-absorbing eyewear as directed.

  1. In a clinical trial to evaluate on-eye performance of TOTAL30® for Astigmatism lenses where n=69. Alcon data on file, 2021.
  2. Based on a clinical trial where n=18. Alcon data on file, 2021.
  3. In vitro analysis of lens oxygen permeability, water content, and surface imaging. Alcon data on file, 2021.
  4. In vitro analysis of lehfilcon A contact lenses outermost surface softness and correlation with water content. Alcon data on file, 2021.
  5. Based on in vitro measurement of thickness profiles on unworn lenses. Alcon data on file, 2021.
  6. Surface observations of lehfilcon A contact lens and human cornea using scanning transmissions electron microscopy. Alcon data on file, 2020.
  7. Shi X, Cantu-Crouch D, Sharma V, et al. Surface characterization of a silicone hydrogel contact lens having bioinspired 2-methacryloyloxyethyl phosphorylcholine polymer layer in hydrated state. Colloids Surf B: Biointerfaces. March 2021;199:111539.
  8. In vitro evaluation of bacterial adherence in commercial lenses. Alcon data on file, 2020.
  9. In vitro evaluation of bacterial biofilm in commercial lenses. Alcon data on file, 2020.
  10. Ishihara K, Fukazawa K, Sharma V, Liang S, et al. Antifouling silicone hydrogel contact lenses with a bioinspired 2 methacryloyloxyethyl phosphorylcholine polymer surface. ACS Omega. 2021;6:7058-7067.
  11. In vitro evaluation of lipid deposition for lehfilcon A and commercial lenses using 3D confocal imaging. Alcon data on file, 2021.
  12. Laboratory assessment of ultraviolet and visible light transmission properties of lehfilcon A contact lenses using spectrophotometer. Alcon data on file, 2020.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-T3A-2400001

TOTAL30™ Multifocal

*Based on 9/10 wearers agreeing with the statement 'while wearing my lenses, I sometimes forget I have them on'

**Based on in vitro studies of unworn sphere lenses.

***There is no demonstrated clinical benefit to a 34% reduction in visible light at wavelengths below 450 nm.

†Based on in vitro measurements of unworn lenses.

††Dk/t @-3.00D = 154

‡ UV absorbing contact lenses are NOT substitutes for protective UV absorbing eyewear, such as UV absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. The patient should continue to use UV absorbing eyewear as directed.

  1. In a clinical study wherein patients used Clear Care® solution for nightly cleaning, disinfecting, and storing. Alcon data on file, 2021.
  2. Alcon data on file, 2022.
  3. Capote-Puente R, Bautista-Llamas MJ, Manzoni C, Sánchez-González JM. Pre-Lens Tear Meniscus Height, Lipid Layer Pattern and Non-Invasive Break-Up Time Short-Term Changes with a Water Gradient Silicone Hydrogel Contact Lens. Life (Basel). 2022;12(11):1710. Published 2022 Oct 26.
  4. Surface property analysis of lehfilcon A lenses out of pack and after 30 days of wear. Alcon data on file, 2020.
  5. Surface observations of lehfilcon A contact lens and human cornea using scanning transmissions electron microscopy. Alcon data on file, 2020.
  6. Capote-Puente R, Bautista-Llamas MJ, Manzoni C, Sánchez-González JM. Pre-Lens Tear Meniscus Height, Lipid Layer Pattern and Non-Invasive Break-Up Time Short-Term Changes with a Water Gradient Silicone Hydrogel Contact Lens. Life (Basel). 2022;12(11):1710. Published 2022 Oct 26.
  7. Capote-Puente R, Bautista-Llamas MJ, Sánchez-González JM. Tear Film Dynamics between Low and High Contact Lens Dry Eye Disease Questionnaire (CLDEQ-8) Score with a Lehfilcon A Silicone Hydrogel Water Gradient Contact Lens: A Non-Invasive Methodology Approach. Diagnostics (Basel). 2023;13(5):939. Published 2023 Mar 1.
  8. Laboratory measurement of oxygen permeability by polarographic method. Alcon data on file, 2019.
  9. In vitro evaluation of bacterial adherence in commercial lenses. Alcon data on file, 2020.
  10. In vitro evaluation of bacterial biofilm in commercial lenses. Alcon data on file, 2020.
  11. Ishihara K, Fukazawa K, Sharma V, Liang S, et al. Antifouling silicone hydrogel contact lenses with a bioinspired 2 methacryloyloxyethyl phosphorylcholine polymer surface. ACS Omega. 2021;6:7058-7067.
  12. In vitro evaluation of lipid deposition for lehfilcon A and commercial lenses using 3D confocal imaging. Alcon data on file, 2021.
  13. Shi X, Cantu-Crouch D, Sharma V, et al. Surface characterization of a silicone hydrogel contact lens having bioinspired 2-methacryloyloxyethyl phosphorylcholine polymer layer in hydrated state. Colloids Surf B: Biointerfaces. March 2021;199:111539.
  14. Surface observations of lehfilcon A contact lens and human cornea using scanning transmissions electron microscopy. Alcon data on file, 2020.
  15. Laboratory assessment of ultraviolet and visible light transmission properties of lehfilcon A contact lenses using spectrophotometer. Alcon data on file, 2020.
  16. Alcon data on file, 2016.
  17. Baker K, Merchea M. Impact of pupil diameter on multifocal contact lens vision. Poster presented at: American Academy of Optometry Annual Conference; November 9, 2018; San Antonio, TX.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-T3M-2400105

OPTI-FREE® Puremoist®

  1. OPTI-FREE® Puremoist® Directions for Use.
  2. Lally J, Ketelson H, Borazjani R, et al. A new lens care solution provides moisture and comfort with today’s CLs. Optician 4/1/2011, Vol 241 Issue 6296, 42-46.
  3. Davis J, Ketelson HA, Shows A, Meadows DL. A lens care solution designed for wetting silicone hydrogel materials. Poster presented at ARVO; May 2010; Fort Lauderdale, FL.
  4. Campbell R, Kame G, et al. Clinical benefits of a new multi-purpose disinfecting solution in silicone hydrogel and soft contact lens users. Eye & Contact Lens 2012:38(2);93-101.
  5. Shannon P, McAnally C, Walter R, et al. Antimicrobial Efficacy of Contact Lens Solutions Assessed by ISO Standards. Poster presented at the Annual Meeting of the American Academey of Optometry, Orlando, FL, October 23-27, 2019.
  6. Rosenthal R, Sutton S, Schlech B. Review of standards for evaluating the effectiveness of contact lens disinfectants. PDA J Pharm Sci And Tech. 2002;56(1):37-50.
  7. Santos L, Oliveira R, Oliveira ME, Azeredo J. Lens material and formulation of multipurpose solutions affects contact lens disinfection. Cont Lens Anterior Eye. 2011;34(4):179-182.
  8. Senchyna M, et al. Characterization of a Multi-Purpose Lens Solution Designed for Silicone Hydrogel Materials. Poster presented at: ARVO; May 2010; Fort Lauderdale, FL.

For contact lens care: See instructions for use for care, precautions, warnings, contraindications and adverse effects.

© 2024 Alcon Inc. CA-OFM-2400001

OPTI-FREE® Express®

  1. Stiegemeier MJ, Cedrone R, Evans D, et al. Clinical performance of 'no rub' multi-purpose solutions. Cont Lens Anterior Eye. 2004;27(2):65-74.
  2. OPTI-FREE® Express Directions for Use.
  3. Rosenthal RA, Buck S, McAnally C, Abshire R, Schlech B. Antimicrobial comparison of a new multi-purpose disinfecting solution to a 3% hydrogen peroxide system. CLAO J. 1999;25(4):213-217.
  4. Santos L, Oliveira R, Oliveira ME, Azeredo J. Lens material and formulation of multipurpose solutions affects contact lens disinfection. Cont Lens Anterior Eye. 2011;34(4):179-182.

For contact lens care: See instructions for use for care, precautions, warnings, contraindications and adverse effects.

© 2024 Alcon Inc. CA-OFX-2400001

CLEAR CARE® PLUS with HydraGlyde®

†PLURONIC is a trademark of BASF

References: CLEAR CARE® PLUS with HydraGlyde® package and instructions For contact lens care: See instructions for use for care, precautions, warnings, contraindications and adverse effects. CLEAR CARE® PLUS and the special lens case provided must always be used together. NEVER clean or rinse your contact lenses in your hands with CLEAR CARE® PLUS. It is not a Multi-Purpose Disinfecting Solution.

© 2024 Alcon Inc. CA-CCS-2400007

CLEAR CARE®

  1. Clear Care Customer Survey 2017. Alcon data on file, 2017.
  2. CIBA Clear Care survey. Alcon data on file, 2007.
  3. LCD913 - P001 - TDOC-0051197 Comparison of two one-step hydrogen peroxide lens care solutions. Alcon data on file, 2016.
  4. Clear Care® Directions for Use.

For contact lens care: See instructions for use for care, precautions, warnings, contraindications and adverse effects.

© 2024 Alcon Inc. CA-CCP-2400010

Systane® COMPLETE

*Based on internal assessment and patient segmentation

**Please refer to instructions for use

^ vs. Systane® BALANCE

  1. Silverstein S, Yeu E, Tauber J, et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177.
  2. Ketelson H, Rangarajan R. Pre-clinical evaluation of a novel phospholipid nanoemulsion based lubricant eye drops. Poster presented at ARVO 2017, Baltimore, MD.
  3. Rangarajan R, Ketelson H. Preclinical evaluation of a new hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear formulation in models of corneal epithelium. J Ocul Pharmacol Ther. 2019;35(1):32-37. TDOC-0051863 v3.0 Research Summary for Formulation ID 119305, Nanoemulsion. Alcon data on file, 2017.
  4. Pucker AD, McGwin G, Jr., Franklin QX, Dubey J, Nattis A.Application of systane complete for the treatment of contact lens discomfort.Cont Lens Anterior Eye. 2021 Aug;44(4):101399. doi: 10.1016/j.clae.2

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SYC-2400009

Systane® COMPLETE PRESERVATIVE-FREE

* Also available in a preserved version

** vs Systane® Balance

*** Based on internal assessment and patient segmentation

**** Please refer to instructions of use

  1. Silverstein S. et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clinical Ophthalmology 2020:14 3167–3177
  2. Lens Care Compatibility report of Systane Complete (FID 119305) with selected contact lenses. February 8, 2023.
  3. Pucker AD, McGwin G, Jr., Franklin QX, Dubey J, Nattis A.Application of systane complete for the treatment of contact lens discomfort.Cont Lens Anterior Eye. 2021 Aug;44(4):101399. doi: 10.1016/j.clae.2020.12.004. Epub 2020 Dec 13
  4. Preservative Uptake & Release Study Report with Systane Complete &CLs. April 27, 2023
  5. TDOC-0051863 v3.0 Research Summary for Formulation ID 119305, Nanoemulsion. 2017
  6. Rangarajan R, Ketelson H. Preclinical evaluation of a new hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear formulation in models of corneal epithelium. Journal of Ocular Pharmacology and Therapeutics. 2019;35(1):32-37. doi:10.1089/jop.2018.0031

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SYX-2400060

Systane® HYDRATION PRESERVATIVE-FREE

* In vitro data

**Also available in a preserved version

****Please refer to instructions for use

  1. Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. J. Ocul. Pharmacol. Ther. 2015;31(8):491-497.
  2. Davitt, WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.
  3. Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278.
  4. Davidson R, Schultz-Scott B, Efficacy evaluation of Systane ULTRA in patients with dry eye undergoing cataract surgery. Poster presented at: 30th Congress of the European Society of Cataract and Refractive Surgeons; September 8-12, 2012; Milan, Italy.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SYY-2400001

Systane® ULTRA

*Based on internal assessment and patient segmentation

**Please refer to instructions for use

  1. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.
  2. Christensen MT, Martin AE, Bloomenstein M. A comparison of efficacy between Systane Ultra and Optive lubricant eye drops when tested with dry eye patients. Optometry. 2009;80(6):315.
  3. Alcon data on file.
  4. Alcon data on file.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SYU-2400002

Systane® HYDRATION

* In vitro data

**Based on internal assessment and patient segmentation

***Please refer to instructions for use

  1. Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. J. Ocul. Pharmacol. Ther. 2015;31(8):491-497.
  2. Davitt, WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.
  3. Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SYH-2400005

Systane® BALANCE

*Based on internal assessment and patient segmentation

**Please refer to instructions for use

  1. Benelli U. Systane lubricant eye drops in the management of ocular dryness. Clin Ophthalmol. 2011:5;783-790.
  2. Korb DR, Blackie CA, Meadows DL, Christensen M, Tudor M. Evaluation of extended tear stability by two emulsion based artificial tears. Poster presented at: 6th International Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance; September 22-25, 2010; Florence, Italy.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SYB-2400002

Systane® GEL DROPS

*Based on internal assessment and patient segmentation

**Please refer to instructions for use

  1. Cohen S, et al. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose. Clin Ophtalmology. 2014;8:157-164.
  2. Christensen M, Martin A, Meadows D. An evaluation of the efficacy and patient acceptance of a new lubricant eye gel. The American Academy of Optometry Annual Meeting; 2011; E-Abstract 115013.
  3. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SGD-2400001

Systane® LID WIPES

  1. National Center for Biotechnology Information. U.S. National Library of Medicine. Available at https://pubchem.ncbi.nlm.nih.gov/source/hsdb/46#section=Overview. Accessed April 2020.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SYW-2400002

Systane® HYDRATION PRESERVATIVE-FREE

* In vitro data

**Also available in a preserved version

****Please refer to instructions for use

  1. Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. J. Ocul. Pharmacol. Ther. 2015;31(8):491-497.
  2. Davitt, WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.
  3. Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278.
  4. Davidson R, Schultz-Scott B, Efficacy evaluation of Systane ULTRA in patients with dry eye undergoing cataract surgery. Poster presented at: 30th Congress of the European Society of Cataract and Refractive Surgeons; September 8-12, 2012; Milan, Italy.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-SYY-2400001

AIR OPTIX™ AQUA

*Dk/t 138 @ -3.00D, Other factors may influence eye health

  1. Eiden SB, Davis R, Bergenske P. Prospective study of Iotrafilcon B lenses comparing 2 versus 4 weeks of wear for objective and subjective measures of health, comfort and vision. Eye & Contact Lens. 2013;39(4):290-294.
  2. Lemp J, Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93:Eabstract 165256.
  3. Nash W, Gabriel M, Mowrey-Mckee M. A comparison of various silicone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci. 2010;87:E-abstract 105110.
  4. Nash W, Gabriel M. Ex vivo analysis of cholesterol deposition for commercially available silicone hydrogel contact lenses using a fluorometric enzymatic assay. Eye Contact Lens. 2014;40(5):277-282.
  5. Lemp J, Kern J. On-eye performance of lotrafilcon B lenses packaged with a substantive wetting agent. Poster presented at Optometry's Meeting, the Annual Meeting of the American Optometric Association; June 21-25, 2017; Washington, D.C.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-AOA-2400002

DAILIES® COLORS

† Mystic Green has a less defined outer ring as compared to other colors. Mystic Green is also available as Green within the FreshLook® One-Day Color contact lenses portfolio.

*Applies only to Mystic Blue, Mystic Gray, Mystic Hazel.

Important information for DAILIES® COLORS (nelfilcon A) contact lenses: For daily wear single use. Contact lenses, even if worn for cosmetic reasons, are medical devices that must only be worn under the prescription direction, and supervision of an eye care professional. Serious eye health problems may occur as a result of sharing contact lenses.

See product instructions for complete wear, care and safety information. © 2024 Alcon Inc. CA-DOC-2400001`

VITALUX® Advanced

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-VLA-2400003

VITALUX® Advanced Chewable

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-VLC-2400001

VITALUX® Advanced Multivitamin

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-VAM-2400001

VITALUX® Advanced Omega-3

Vitalux® Advanced+Omega-3 Product License.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-VCO-2400002

VITALUX® Healthy Eyes

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-VLH-2400001

VITALUX® S

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-VLS-2400001

VITALUX® Advanced Softgel

  1. Vitalux® Advanced Soft Gel Product License.

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-VLS-2400002

Alcon Tears

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-ITT-2400001

GenTealTM Tears

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-GNT-2400001

Lid-CareTM

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-SYW-2400001

Naphcon ATM

See instructions for use, precautions, warnings and contraindications

© 2024 Alcon Inc. CA-NPA-2400001

OPTIFREE® Replenish®

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-OFR-2400001

SYSTANE® Bion Tears

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-BIT-2400001

SYSTANE® Complete Day & Night

Systane® COMPLETE

*Based on internal assessment and patient segmentation

**Please refer to instructions for use

^ vs. Systane® BALANCE

  1. Silverstein S, Yeu E, Tauber J, et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177.
  2. Ketelson H, Rangarajan R. Pre-clinical evaluation of a novel phospholipid nanoemulsion based lubricant eye drops. Poster presented at ARVO 2017, Baltimore, MD.
  3. Rangarajan R, Ketelson H. Preclinical evaluation of a new hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear formulation in models of corneal epithelium. J Ocul Pharmacol Ther. 2019;35(1):32-37.
  4. TDOC-0051863 v3.0 Research Summary for Formulation ID 119305, Nanoemulsion. Alcon data on file, 2017.
  5. Pucker AD, McGwin G, Jr., Franklin QX, Dubey J, Nattis A.Application of systane complete for the treatment of contact lens discomfort.Cont Lens Anterior Eye. 2021 Aug;44(4):101399. doi: 10.1016/j.clae.2

See instructions for use, precautions, warnings and contraindications

Systane® GEL DROPS

*Based on internal assessment and patient segmentation

**Please refer to instructions for use

  1. Cohen S, et al. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose. Clin Ophtalmology. 2014;8:157-164.
  2. Christensen M, Martin A, Meadows D. An evaluation of the efficacy and patient acceptance of a new lubricant eye gel. The American Academy of Optometry Annual Meeting; 2011; E-Abstract 115013.
  3. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.

See instructions for use, precautions, warnings and contraindications© 2024 Alcon Inc. CA-SYB-2400001

SYSTANE® Gel

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-SYG-2400001

SYSTANE® Night Time

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-SYN-2400002

SYSTANE® Omega-3

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-SYO-2400001

SYSTANE® Original

*Alcon data on file.

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-SYD-2400003

TEARS NATURALE FREETM

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-TNF-2400001

Tears Naturale IITM

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-TNO-2400001

Tears Naturale ForteTM

See instructions for use, precautions, warnings and contraindications.

© 2024 Alcon Inc. CA-TN-2400001

Key
pdp
Country
Canada
User Type
All
Application
MyAlconStore